Seliga-Siwecka Joanna, Płotko Ariel, Wójcik-Sep Agata, Bokiniec Renata, Latka-Grot Julita, Żuk Małgorzata, Furmańczyk Konrad, Zieliński Wojciech, Chrzanowska Mariola
Department of Neonatology and Neonatal Intensive Care, Medical University of Warsaw, Warsaw, Poland.
Department of Neonatology, Children's Health Memorial Institute, Warsaw, Poland.
Front Cardiovasc Med. 2022 Sep 8;9:893764. doi: 10.3389/fcvm.2022.893764. eCollection 2022.
Infants with duct dependent heart lesions often require invasive procedures during the neonatal or early infancy period. These patients remain a challenge for pediatric cardiologists, neonatologists, and intensive care unit personnel. A relevant portion of these infant suffer from respiratory, cardiac failure and may develop NEC, which leads to inadequate growth and nutrition, causing delayed or complicated cardiac surgery.
This randomized control trial will recruit term infants diagnosed with a duct dependant lesion within the first 72 h of life. After obtaining written parental consent patients will be randomized to either the physician led enteral feeding or protocol-based feeding group. The intervention will continue up to 28 days of life or day of cardiosurgical treatment, whichever comes first. The primary outcomes include NEC and death related to NEC. Secondary outcomes include among others, number of interrupted feedings, growth velocity, daily protein and caloric intake, days to reach full enteral feeding and on mechanical ventilation.
Our study will be the first randomized control trial to evaluate if standard (as in healthy newborns) initiation and advancement of enteral feeding is safe, improves short term outcomes and does not increase the risk of NEC. If the studied feeding regime proves to be intact, swift implementation and advancement of enteral nutrition may become a recommendation.
The study protocol has been approved by the local ethical board. It is registered at ClinicalTrials.gov NCT05117164.
患有依赖动脉导管的心脏病变的婴儿在新生儿期或婴儿早期通常需要进行侵入性手术。对于儿科心脏病专家、新生儿科医生和重症监护室人员来说,这些患者仍然是一个挑战。这些婴儿中有相当一部分患有呼吸、心力衰竭,可能会发展为坏死性小肠结肠炎,这会导致生长和营养不足,从而导致心脏手术延迟或出现并发症。
这项随机对照试验将招募在出生后72小时内被诊断患有依赖动脉导管病变的足月儿。在获得家长书面同意后,患者将被随机分为医生主导的肠内喂养组或基于方案的喂养组。干预将持续到出生后28天或心脏外科治疗日,以先到者为准。主要结局包括坏死性小肠结肠炎及与坏死性小肠结肠炎相关的死亡。次要结局包括中断喂养的次数、生长速度、每日蛋白质和热量摄入量、达到完全肠内喂养的天数以及机械通气天数等。
我们的研究将是第一项评估标准(如健康新生儿)启动和推进肠内喂养是否安全、能否改善短期结局且不增加坏死性小肠结肠炎风险的随机对照试验。如果所研究的喂养方案被证明是完整的,那么迅速实施和推进肠内营养可能会成为一项推荐措施。
该研究方案已获得当地伦理委员会的批准。它已在ClinicalTrials.gov上注册,注册号为NCT05117164。